Patent Assignment
Reel/Frame 062006/0277
Assignment of Assignor's Interest
Recorded: 2022-12-07
Pages: 11
Assignors
NAIR, JAYAPRAKASH K.
Executed: 2022-11-29
MAIER, MARTIN A.
Executed: 2022-11-30
JADHAV, VASANT R.
Executed: 2022-11-30
KEATING, MARK
Executed: 2022-12-01
FITZGERALD, KEVIN
Executed: 2022-11-29
MILSTEIN, STUART
Executed: 2022-12-01
PETRULIS, JOHN R.
Executed: 2022-12-06
Assignee
ALNYLAM PHARMACEUTICALS, INC.
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MASSACHUSETTS, 02142-1110
Covered Properties
(2)
Transthyretin (Ttr) Irna Composition and Methods of Use Thereof for Treating or Preventing Ttr-Associated Ocular Diseases
PCT:
PCT/US2020/059070 ↗
TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES
Application:
17/736,251 →
Publication:
US 2023/0304002
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 15, 2022
From: NAIR, JAYAPRAKASH K.; MAIER, MARTIN A.; JADHAV, VASANT R.; KEATING, MARK
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 061768/0551 →
Security Interest
Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →